R. Hamutcu, J. M. Rowland, and M. V. Horn, Clinical findings and lung pathology in children with cystic fibrosis, Am J Respir Crit Care Med, vol.165, pp.1172-1175, 2002.
DOI : 10.1164/ajrccm.165.8.2104090

B. M. Morrissey, B. C. Schock, G. P. Marelich, and C. E. Cross, Cystic fibrosis in adults: current and future management strategies, Clin Rev Allergy Immunol, vol.25, pp.275-287, 2003.
DOI : 10.1385/criai:25:3:275

J. R. Riordan, CFTR function and prospects for therapy, Annu Rev Biochem, vol.77, pp.701-726, 2008.
DOI : 10.1146/annurev.biochem.75.103004.142532

O. Moran, The biophysics, biochemistry and physiology of CFTR, Cell Mol Life Sci, vol.74, pp.1-2, 2017.

C. Castellani and B. M. Assael, Cystic fibrosis: a clinical view, Cell Mol Life Sci, vol.74, pp.129-140, 2017.

A. M. George, P. M. Jones, and P. G. Middleton, Cystic fibrosis infections: treatment strategies and prospects, FEMS Microbiol Lett, vol.300, pp.153-164, 2009.
DOI : 10.1111/j.1574-6968.2009.01704.x

M. Cohen-cymberknoh, D. Shoseyov, and E. Kerem, Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life, Am J Respir Crit Care Med, vol.183, pp.1463-1471, 2011.

K. M. Langan, T. Kotsimbos, and A. Y. Peleg, Managing Pseudomonas aeruginosa respiratory infections in cystic fibrosis, Curr Opin Infect Dis, vol.28, pp.547-556, 2015.
DOI : 10.1097/qco.0000000000000217

M. Pihet, J. Carrère, and B. Cimon, Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis-a review, Med Mycol, vol.47, pp.387-397, 2009.

M. ¨-uller, F. M. Seidler, and M. , Characteristics of pathogenic fungi and antifungal therapy in cystic fibrosis, Expert Rev Anti Infect Ther, vol.8, pp.957-964, 2010.

P. G. Middleton, S. C. Chen, and W. Meyer, Fungal infections and treatment in cystic fibrosis, Curr Opin Pulm Med, vol.19, pp.670-675, 2013.
DOI : 10.1097/mcp.0b013e328365ab74

S. H. Chotirmall and N. G. Mcelvaney, Fungi in the cystic fibrosis lung: bystanders or pathogens?, Int J Biochem Cell Biol, vol.52, pp.161-173, 2014.

C. Williams, R. Ranjendran, and G. Ramage, Pathogenesis of fungal infections in cystic fibrosis, Curr Fungal Infect Rep, vol.10, pp.163-169, 2016.

A. M. Borman, M. D. Palmer, and L. Delhaes, Lack of standardization in the procedures for mycological examination of sputum samples from CF patients: a possible cause for variations in the prevalence of filamentous fungi, Med Mycol, vol.48, pp.88-97, 2010.
URL : https://hal.archives-ouvertes.fr/hal-01118199

F. J. Accurso, Update in cystic fibrosis, Am J Respir Crit Care Med, vol.173, pp.944-947, 2005.

A. Elizur, C. L. Cannon, and T. W. Ferkol, Airway inflammation in cystic fibrosis, Chest, vol.133, pp.489-495, 2008.

J. L. Burns, R. L. Gibson, and S. Mcnamara, Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis, J Infect Dis, vol.183, pp.444-452, 2001.

D. ¨-oring, G. Flume, P. Heijerman, H. Elborn, and J. S. , Group Consensus Study. Treatment of lung infection in patients with cystic fibrosis: current and future strategies, J Cyst Fibros, vol.11, pp.461-479, 2012.

R. Horré, F. Symoens, L. Delhaes, and J. P. Bouchara, Fungal respiratory infections in cystic fibrosis: a growing problem, Med Mycol, vol.48, pp.1-3, 2010.

R. L. Gibson, J. L. Burns, and B. W. Ramsey, Pathophysiology and management of pulmonary infections in cystic fibrosis, Am J Respir Crit Care Med, vol.168, pp.918-951, 2003.

C. R. Sudfeld, E. C. Dasenbrook, W. G. Merz, K. C. Carroll, and M. P. Boyle, Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis, J Cyst Fibros, vol.9, pp.110-116, 2010.

S. A. Maskarinec, M. D. Johnson, and J. R. Perfect, Genetic susceptibility to fungal infections: what is in the genes?, Curr Clin Microbiol Rep, vol.3, pp.81-91, 2016.

N. L. Overton, D. W. Denning, P. Bowyer, and A. Simpson, Genetic susceptibility to allergic bronchopulmonary aspergillosis in asthma: a genetic association study, Allergy Asthma Clin Immunol, vol.12, p.47, 2016.

B. Chauhan, L. Santiago, and P. S. Hutcheson, Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis, J Allergy Clin Immunol, vol.106, pp.723-729, 2000.

M. Muro, P. Mondejar-l-´-opez, and M. Mr, HLA-DRB1 and HLA-DQB1 genes on susceptibility to and protection from allergic bronchopulmonary aspergillosis in patients with cystic fibrosis, Microbiol Immunol, vol.57, pp.193-197, 2013.

J. Brouard, N. Knauer, and P. Y. Boelle, Influence of interleukin-10 on Aspergillus fumigatus infection in patients with cystic fibrosis, J Infect Dis, vol.191, pp.1988-1991, 2005.

A. P. Knutsen, B. Kariuki, J. D. Consolino, and M. R. Warrier, IL-4 alpha chain receptor (IL-4Ralpha) polymorphisms in allergic bronchopulmonary aspergillosis, Clin Mol Allergy, vol.4, p.3, 2006.

A. Bauernfeind, R. M. Bertele, and K. Harms, Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis, Infection, vol.15, pp.270-277, 1987.

L. Masoud-landgraf, A. Badura, E. Eber, G. Feierl, M. E. Buzina et al., Modified culture method detects a high diversity of fungal species in cystic fibrosis patients, Med Mycol, vol.52, pp.179-186, 2014.

C. H. Pashley, A. Fairs, and J. P. Morley, Routine processing procedures for isolating filamentous fungi from respiratory sputum samples may underestimate fungal prevalence, Med Mycol, vol.50, pp.433-438, 2012.
DOI : 10.3109/13693786.2011.615762

URL : https://academic.oup.com/mmy/article-pdf/50/4/433/4002939/50-4-433.pdf

N. Bakare, V. Rickerts, J. Bargon, and G. Just-n-¨-ubling, Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis, Mycoses, vol.46, pp.19-23, 2003.

Y. Nagano, B. C. Millar, and C. E. Goldsmith, Development of selective media for the isolation of yeasts and filamentous fungi from the sputum of adult patients with cystic fibrosis (CF), J Cyst Fibros, vol.7, pp.566-572, 2008.

Y. Nagano, J. S. Elborn, and B. C. Millar, Comparison of techniques to examine the diversity of fungi in adult patients with cystic fibrosis, Med Mycol, vol.48, pp.166-176, 2010.

B. Cimon, J. Carrère, J. F. Vinatier, J. P. Chazalette, D. Chabasse et al., Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis, Eur J Clin Microbiol Infect Dis, vol.19, pp.53-56, 2000.

P. Plésiat, J. L. Herrmann, and A. Ferroni, Infections broncho-pulmonaires et mucoviscidose. Rémic, Référentiel en microbiologie médicale, 5` eméemé edition 2015, Société Française de Microbiologie, vol.5, issue.1, pp.193-200, 2015.

F. P. Downes and K. Ito, Compendium of Methods for the Microbiological Examination of Foods, 2001.

A. D. Hocking and J. I. Pitt, Dichloran-glycerol medium for enumeration of xerophilic fungi from low-moisture foods, Appl Environ Microbiol, vol.39, pp.488-492, 1980.

B. Jarvis, Comparison of an improved rose bengal-chlortetracycline agar with other media for the selective isolation and enumeration of moulds and yeasts in foods, J Appl Bacteriol, vol.36, pp.723-727, 1973.

A. D. King, A. D. Hocking, and J. I. Pitt, Dichloran-rose bengal medium for enumeration and isolation of molds from foods, Appl Environ Microbiol, vol.37, pp.959-964, 1979.

R. C. Summerbell, The benomyl test as a fundamental diagnostic method for medical mycology, J Clin Microbiol, vol.31, pp.572-577, 1993.

J. Rainer, J. Kaltseis, S. G. De-hoog, and R. C. Summerbell, Efficacy of a selective isolation procedure for members of the Pseudallescheria boydii complex, Antonie Van Leeuwenhoek, vol.93, pp.315-322, 2008.

R. Horré, G. Marklein, R. Siekmeier, S. Nidermajer, and S. M. Reiffert, Selective isolation of Pseudallescheria and Scedosporium species from respiratory tract specimens of cystic fibrosis patients, Respiration, vol.77, pp.320-324, 2009.

R. Horré, G. Marklein, R. Siekmeier, and S. M. Reiffert, Detection of hyphomycetes in the upper respiratory tract of patients with cystic fibrosis, Mycoses, vol.54, pp.514-522, 2011.

L. Sedlacek, B. Graf, and C. Schwarz, Prevalence of Scedosporium species and Lomentospora prolificans in patients with cystic fibrosis in a multicenter trial by use of a selective medium, J Cyst Fibros, vol.14, pp.237-241, 2015.

C. C. Blyth, A. Harun, and P. G. Middleton, Detection of occult Scedosporium species in respiratory tract specimens from patients with cystic fibrosis by use of selective media, J Clin Microbiol, vol.48, pp.314-316, 2010.

C. L. Schoch, K. A. Seifert, and S. Huhndorf, The nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for fungi, Proc Natl Acad Sci, vol.109, pp.6241-6246, 2012.

A. Alastruey-izquierdo and E. Mellado, Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP Study), Antimicrob Agents Chemother, vol.57, pp.3380-3387, 2013.

F. Gilgado, J. Cano, J. Gené, and J. Guarro, Molecular phylogeny of the Pseudallescheria boydii species complex: proposal of two new species, J Clin Microbiol, vol.43, pp.4930-4942, 2005.

J. Houbraken, S. Giraud, and M. Meijer, Taxonomy and antifungal susceptibility of clinically important Rasamsonia species, J Clin Microbiol, vol.51, pp.22-30, 2013.

A. Croxatto, G. Prod'hom, and G. Greub, Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology, FEMS Microbiol Rev, vol.36, pp.380-407, 2012.

A. Ferroni, S. Suarez, and J. L. Beretti, Real-time identification of bacteria and Candida species in positive blood culture broths by matrix-assisted laser desorption ionization-time of flight mass spectrometry, J Clin Microbiol, vol.48, pp.1542-1548, 2010.
URL : https://hal.archives-ouvertes.fr/pasteur-01405255

B. Posteraro, D. Carolis, A. Vella, and M. Sanguinetti, MALDI-TOF mass spectrometry in the clinical mycology laboratory: identification of fungi and beyond, Expert Rev Proteomics, vol.10, pp.151-164, 2013.

J. M. Hettick, B. J. Green, and A. D. Buskirk, Discrimination of Penicillium isolates by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry fingerprinting, Rapid Commun Mass Spectrom, vol.22, pp.2555-2560, 2008.

E. De-carolis and B. Posteraro, Lass-Fï orl C et al. Species identification of

. Aspergillus, Fusarium and Mucorales with direct surface analysis by matrix-assisted laser desorption ionization time-of-flight mass spectrometry, Clin Microbiol Infect, vol.18, pp.475-484, 2012.

E. Sitterlé, S. Giraud, and J. Leto, Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and accurate identification of Pseudallescheria/Scedosporium species, Clin Microbiol Infect, vol.20, pp.929-935, 2014.

D. Triest, D. Stubbe, D. Cremer, and K. , Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of molds of the Fusarium genus, J Clin Microbiol, vol.53, pp.465-476, 2015.

S. Sleiman, C. L. Halliday, and B. Chapman, Performance of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of Aspergillus, Scedosporium, and Fusarium spp. in the Australian clinical setting, J Clin Microbiol, vol.54, pp.2182-2186, 2016.

C. Cassagne, S. Ranque, and A. C. Normand, Mould routine identification in the clinical laboratory by matrix-assisted laser desorption ionization time-of-flight mass spectrometry, PloS One, vol.6, p.28425, 2011.

A. F. Lau, S. K. Drake, L. B. Calhoun, C. M. Henderson, and A. M. Zelazny, Development of a clinically comprehensive database and a simple procedure for identification of molds from solid media by matrix-assisted laser desorption ionization-time of flight mass spectrometry, J Clin Microbiol, vol.51, pp.828-834, 2013.

L. Vanhee, H. J. Nelis, and T. Coenye, What can be learned from genotyping of fungi?, Med Mycol, vol.48, pp.60-69, 2010.

A. Harun, H. Perdomo, and F. Gilgado, Genotyping of Scedosporium species: a review of molecular approaches, Med Mycol, vol.47, pp.406-414, 2009.

J. Kaur, S. Y. Duan, and L. A. Vaas, Phenotypic profiling of Scedosporium aurantiacum, an opportunistic pathogen colonizing human lungs, PLoS One, vol.10, p.122354, 2015.
DOI : 10.1371/journal.pone.0122354

URL : https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0122354&type=printable

A. Bernhardt, L. Sedlacek, S. Wagner, C. Schwarz, B. Tintelnot et al.,

, Multilocus sequence typing of Scedosporium apiospermum and Pseudallescheria boydii isolates from cystic fibrosis patients, J Cyst Fibros, vol.12, pp.592-598, 2013.

O. Matray, A. Mouhajir, and G. S. , Semi-automated repetitive sequence-based PCR amplification for species of the Scedosporium apiospermum complex, Med Mycol, vol.54, pp.409-419, 2016.

A. Defontaine, R. Zouhair, and B. Cimon, Genotyping study of Scedosporium apiospermum isolates from patients with cystic fibrosis, J Clin Microbiol, vol.40, pp.2108-2114, 2002.

L. Vanhee, F. Symoens, J. P. Bouchara, H. J. Nelis, and T. Coenye, Highresolution genotyping of Aspergillus fumigatus isolates recovered from chronically colonised patients with cystic fibrosis, Eur J Clin Microbiol Infect Dis, vol.27, pp.1005-1007, 2008.
DOI : 10.1007/s10096-008-0527-1

URL : http://hdl.handle.net/1854/LU-481100

A. Rougeron, S. Giraud, B. Razafimandimby, J. F. Meis, J. P. Bouchara et al., Different colonization patterns of Aspergillus terreus in patients with cystic fibrosis, Clin Microbiol Infect, vol.20, pp.327-333, 2014.

A. Mouhajir, O. Matray, and G. S. , Long-term Rasamsonia argillacea complex species colonization revealed by PCR amplification of repetitive DNA sequences in cystic fibrosis patients, J Clin Microbiol, vol.54, pp.2804-2812, 2016.

J. Steinmann, S. Giraud, and D. Schmidt, Validation of a novel real-time PCR for detecting Rasamsonia argillacea species complex in respiratory secretions from cystic fibrosis patients, New Microbes New Infect, vol.2, pp.72-78, 2014.

J. P. Bouchara, H. Y. Hsieh, and S. Croquefer, Development of an oligonucleotide array for direct detection of fungi in sputum samples from patients with cystic fibrosis, J Clin Microbiol, vol.47, pp.142-152, 2009.

J. Mounier, A. Gouëllo, and M. Keravec, Use of denaturing highperformance liquid chromatography (DHPLC) to characterize the bacterial and fungal airway microbiota of cystic fibrosis patients, J Microbiol, vol.52, pp.307-314, 2014.

R. Kramer, A. Sauer-heilborn, T. Welte, C. A. Guzman, W. R. Abraham et al., Cohort study of airway mycobiome in adult cystic fibrosis patients: differences in community structure between fungi and bacteria reveal predominance of transient fungal elements, J Clin Microbiol, vol.53, pp.2900-2907, 2015.

L. Delhaes, S. Monchy, and E. Fréalle, The airway microbiota in cystic fibrosis: a complex fungal and bacterial community-implications for therapeutic management, PloS One, vol.7, p.36313, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00806782

S. D. Willger, S. L. Grim, and E. L. Dolben, Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosis, Microbiome, vol.2, p.40, 2014.

M. Syhre, J. M. Scotter, and S. T. Chambers, Investigation into the production of 2-pentylfuran by Aspergillus fumigatus and other respiratory pathogens in vitro and human breath samples, Med Mycol, vol.46, pp.209-215, 2008.

S. T. Chambers, M. Syhre, D. R. Murdoch, F. Mccartin, and M. J. Epton, Detection of 2-pentylfuran in the breath of patients with Aspergillus fumigatus, Med Mycol, vol.47, pp.468-476, 2009.

A. H. Neerincx, B. P. Geurts, and M. F. Habets, Identification of Pseudomonas aeruginosa and Aspergillus fumigatus mono-and co-cultures based on volatile biomarker combinations, J Breath Res, vol.10, p.16002, 2016.

S. Bertrand, G. Larcher, A. Landreau, P. Richomme, O. Duval et al., Hydroxamate siderophores of Scedosporium apiospermum, Biometals, vol.22, pp.1019-1029, 2009.

S. Bertrand, J. P. Bouchara, M. C. Venier, P. Richomme, O. Duval et al., N(?)-methyl coprogen B, a potential marker of the airway colonization by Scedosporium apiospermum in patients with cystic fibrosis, Med Mycol, vol.48, pp.98-107, 2010.

L. B. Cerqueira, T. M. Francisco, J. C. Gasparetto, F. R. Campos, and R. Pontarolo, Development and validation of an HPLC-MS/MS method for the early diagnosis of aspergillosis, PLoS One, vol.9, p.92851, 2014.

M. P. Domingo, C. Colmenarejo, and L. Martínez-lostao, Bis(methyl)gliotoxin proves to be a more stable and reliable marker for invasive aspergillosis than gliotoxin and suitable for use in diagnosis, Diagn Microbiol Infect Dis, vol.73, pp.57-64, 2012.

M. Vidal-garcía, M. P. Domingo, D. Rueda, and B. , Clinical validity of bis(methylthio)gliotoxin for the diagnosis of invasive aspergillosis, Appl Microbiol Biotechnol, vol.100, pp.2327-2334, 2016.

C. G. Baxter, G. Dunn, and A. M. Jones, Novel immunologic classification of aspergillosis in adult cystic fibrosis, J Allergy Clin Immunol, vol.132, pp.560-566, 2013.

K. R. Jat, D. K. Walia, and A. Khairwa, Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis, Cochrane Database Syst Rev, p.10288, 2013.

L. Delhaes, E. Frealle, and C. Pinel, Serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis: state of the art and further challenges, Med Mycol, vol.48, pp.77-87, 2010.

P. Latzin, D. Hartl, N. Regamey, U. Frey, M. H. Schoeni et al., Comparison of serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis, Eur Respir J, vol.31, pp.36-42, 2008.

C. Casaulta, S. Fï-uckiger, R. Crameri, K. Blaser, and M. H. Schoeni, Time course of antibody response to recombinant Aspergillus fumigatus antigens in cystic fibrosis with and without ABPA, Pediatr Allergy Immunol, vol.16, pp.217-225, 2005.

H. Fricker-hidalgo, B. Coltey, and C. Llerena, Recombinant allergens combined with biological markers in the diagnosis of allergic bronchopulmonary aspergillosis in cystic fibrosis patients. Clin Vaccine Immunol, vol.17, pp.1330-1336, 2010.

Y. Gernez, J. Walters, and B. Mirkovi´cmirkovi´c, Blood basophil activation is a reliable biomarker of allergic bronchopulmonary aspergillosis in cystic fibrosis, Eur Respir J, vol.47, pp.177-185, 2016.

A. Katelari, M. Tzanoudaki, and N. M. , The role of basophil activation test in allergic bronchopulmonary aspergillosis and Aspergillus fumigatus sensitization in cystic fibrosis patients, J Cyst Fibros, vol.15, pp.587-596, 2016.

C. Barrera, B. Richaud-thiriez, and S. Rocchi, New commercially available IgG kits and Time-Resolved Fluorometric IgE assay for diagnosis of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis, Clin Vaccine Immunol, vol.23, pp.196-203, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01294619

C. Dumollard, S. Bailly, and S. Perriot, Prospective evaluation of a new Aspergillus IgG enzyme immunoassay kit for diagnosis of chronic and allergic pulmonary aspergillosis, J Clin Microbiol, vol.54, pp.1236-1242, 2016.

P. Parize, S. Billaud, and A. L. Bienvenu, Impact of Scedosporium apiospermum complex seroprevalence in patients with cystic fibrosis, J Cyst Fibros, vol.13, pp.667-673, 2014.

S. Mina, A. Marot-leblond, and B. Cimon, Purification and characterization of a mycelial catalase from Scedosporium boydii, a useful tool for specific antibody detection in patients with cystic fibrosis, Clin Vaccine Immunol, vol.22, pp.37-45, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01390731

S. Mina, C. Staerck, and S. M. Almeida, Identification of Scedosporium boydii catalase A1 gene, a reactive oxygen species detoxification factor highly expressed in response to oxidative stress and phagocytic cells, Fungal Biol, vol.119, pp.1322-1333, 2015.

A. Pellon, A. Ramirez-garcia, I. Buldain, A. Antoran, and A. Rementeria, Hernando FL. Immunoproteomics-based analysis of the immunocompetent serological response to Lomentospora prolificans, J Proteome Res, vol.15, pp.595-607, 2016.

G. Larcher, B. Cimon, F. Symoens, G. Tronchin, D. Chabasse et al., A 33 kDa serine proteinase from Scedosporium apiospermum, Biochem J, vol.315, pp.119-126, 1996.

B. A. Silva, M. R. Pinto, R. M. Soares, E. Barreto-bergter, and A. L. Santos, Pseudallescheria boydii releases metallopeptidases capable of cleaving several proteinaceous compounds, Res Microbiol, vol.157, pp.425-432, 2006.
DOI : 10.1016/j.resmic.2005.11.010

M. M. Pereira, B. A. Silva, M. R. Pinto, E. Barreto-bergter, and A. L. Santos, Proteins and peptidases from conidia and mycelia of Scedosporium apiospermum strain HLPB, Mycopathologia, vol.167, pp.25-30, 2009.
DOI : 10.1007/s11046-008-9147-7

O. C. Lima, G. Larcher, and P. Vandeputte, Molecular cloning and biochemical characterization of a Cu,Zn-superoxide dismutase from Scedosporium apiospermum, Microbes Infect, vol.9, pp.558-565, 2007.

S. Ghamrawi, G. Rénier, and P. Saulnier, Cell wall modifications during conidial maturation of the human pathogenic fungus Pseudallescheria boydii, PLoS One, vol.9, p.100290, 2014.

P. Vandeputte, S. Ghamrawi, and M. Rechenmann, Draft genome sequence of the pathogenic fungus Scedosporium apiospermum, Genome Announc, vol.2, pp.988-1002, 2014.

S. Al-khodor, C. T. Price, A. Kalia, A. Kwaik, and Y. , Functional diversity of ankyrin repeats in microbial proteins, Trends Microbiol, vol.18, pp.132-129, 2010.

. Åpérez-bercoff, . Papanicolaou, and M. Ramsperger, Draft genome of Australian environmental strain WM 09.24 of the opportunistic human pathogen Scedosporium aurantiacum, Genome Announc, vol.3, pp.1526-1540, 2015.

L. Duvaux, J. Shiller, and P. Vandeputte, Draft genome sequence of the human pathogenic fungus Scedosporium boydii, Genome Announc, 2017.

A. Ramirez-garcia, A. Pellon, and I. Buldain, Proteomics as a tool to identify new targets Aspergillus and Scedosporium in the context of cystic fibrosis, 2017.

S. Ghamrawi, A. Gastebois, and A. Zykwinska, A multifaceted study of Scedosporium boydii cell wall changes during germination and identification of GPI-anchored proteins, PLoS One, vol.10, p.128680, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01392256

T. C. Cairns, D. J. Studholme, N. J. Talbot, and K. Haynes, New and improved techniques for the study of pathogenic fungi, Trends Microbiol, vol.24, pp.35-50, 2016.

A. Al-laaeiby, M. J. Kershaw, T. J. Penn, and C. R. Thornton, Targeted disruption of melanin biosynthesis genes in the human pathogenic fungus Lomentospora prolificans and its consequences for pathogen survival, Int J Mol Sci, vol.17, p.444, 2016.

S. Krappmann, Genetic surgery in fungi: employing site-specific recombinases for genome manipulation, Appl Microbiol Biotechnol, vol.98, pp.1971-1982, 2014.

N. Papon, V. Courdavault, A. Lanoue, M. Clastre, and M. Brock, Illuminating fungal infections with bioluminescence, PLoS Pathog, vol.10, p.1004179, 2014.
DOI : 10.1371/journal.ppat.1004179

URL : https://hal.archives-ouvertes.fr/hal-01160160

A. Kegel, P. Martinez, S. D. Carter, and S. U. Aströmastr¨aström, Genome wide distribution of illegitimate recombination events in Kluyveromyces lactis, Nucleic Acids Res, vol.34, pp.1633-1645, 2006.

F. Wanka, T. Cairns, and S. Boecker, Tet-on, or Tet-off, that is the question: Advanced conditional gene expression in Aspergillus, Fungal Genet Biol, vol.89, pp.72-83, 2016.

M. Cuenca-estrella, B. Ruiz-díez, J. V. Martínez-sú-arez, A. Monzónmonz´monzón, and J. L. Rodríguez-tudela, Comparative in-vitro activity of voriconazole (UK109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum, J Antimicrob Chemother, vol.43, pp.149-151, 1999.

A. J. Carrillo and J. Guarro, In vitro activities of four novel triazoles against Scedosporium spp, Antimicrob Agents Chemother, vol.45, pp.2151-2153, 2001.

J. Meletiadis, J. F. Meis, J. W. Mouton, J. L. Rodriquez-tudela, J. P. Donnelly et al., vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates, vol.46, pp.62-68, 2002.
DOI : 10.1128/aac.46.1.62-68.2002

URL : https://aac.asm.org/content/aac/46/1/62.full.pdf

F. Gilgado, C. Serena, J. Cano, J. Gené, and J. Guarro, Antifungal susceptibilities of the species of the Pseudallescheria boydii complex, Antimicrob Agents Chemother, vol.50, pp.4211-4213, 2006.

J. Guinea, T. Recio, S. Torres-narbona, M. Bouza, and E. , In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species, Antimicrob Agents Chemother, vol.52, pp.1396-1400, 2008.

M. Lackner, G. S. De-hoog, and P. E. Verweij, Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species. Antimicrob Agents Chemother, vol.56, pp.2635-2642, 2012.

D. Chabasse, J. P. Bouchara, and J. P. Chazalette, Mucoviscidose et colonisation fongiquè a Scedosporium apiospermum. A propos de trois observations, J Mycol Méd, vol.1, pp.152-155, 1991.

A. M. Tortorano, M. Richardson, and E. Roilides, European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study Group; European Confederation of Medical Mycology. ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others, Clin Microbiol Infect, vol.20, pp.27-46, 2014.

M. Lackner, A. Rezusta, M. C. Villuendas, M. P. Palacian, J. F. Meis et al., Infection and colonisation due to Scedosporium in Northern Spain. An in vitro antifungal susceptibility and molecular epidemiology study of 60 isolates, Mycoses, vol.54, pp.12-21, 2011.

M. Cuenca-estrella, A. Alastruey-izquierdo, and L. Alcazar-fuoli, In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans, Antimicrob Agents Chemother, vol.52, pp.1136-1139, 2008.

A. Martin-vicente, J. Guarro, and J. Capilla, Does a triple combination have better activity than double combinations against multiresistant fungi? Experimental in vitro evaluation, Int J Antimicrob Agents, vol.49, pp.422-426, 2017.

K. J. Cortez, E. Roilides, and F. Quiroz-telles, Infections caused by Scedosporium spp, Clin Microbiol Rev, vol.21, pp.157-197, 2008.

J. Meletiadis, J. W. Mouton, J. F. Meis, and P. E. Verweij, Combination chemotherapy for the treatment of invasive infections by Scedosporium prolificans, Clin Microbiol Infect, vol.6, pp.336-337, 2000.

J. Meletiadis, J. W. Mouton, J. F. Meis, and P. E. Verweij, In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates, Antimicrob Agents Chemother, vol.47, pp.106-117, 2003.

M. M. Rodríguez, E. Calvo, C. Serena, M. Mariné, F. J. Pastor et al., Effects of double and triple combinations of antifungal drugs in a murine model of disseminated infection by Scedosporium prolificans, Antimicrob Agents Chemother, vol.53, pp.2153-2155, 2009.

J. Holle, M. Leichsenring, and P. E. Meissner, Nebulized voriconazole in infections with Scedosporium apiospermum-case report and review of the literature, J Cyst Fibros, vol.13, pp.400-402, 2014.

C. Schwarz, A. Thronicke, D. Staab, and K. Tintelnot, Scedosporium apiospermum: a fungal pathogen causing pneumonia in a patient with cystic fibrosis, JMM Case Rep, vol.2, 2015.

R. Padoan, P. Poli, D. Colombrita, E. Borghi, S. Timpano et al., Acute Scedosporium apiospermum endobronchial infection in cystic fibrosis, Pediatr Infect Dis J, vol.35, pp.701-702, 2016.

C. Schwarz, C. Brandt, and E. Antweiler, Prospective multicenter German study on pulmonary colonization with Scedosporium /Lomentospora species in cystic fibrosis: Epidemiology and new association factors, PloS One, vol.12, p.171485, 2017.

M. R. Vagefi, E. T. Kim, R. G. Alvarado, J. L. Duncan, E. L. Howes et al., Bilateral endogenous Scedosporium prolificans endophthalmitis after lung transplantation, Am J Ophthalmol, vol.139, pp.370-373, 2005.

B. Balandin, M. Aguilar, and S. , Scedosporium apiospermum and S. prolificans mixed disseminated infection in a lung transplant recipient: An unusual case of long-term survival with combined systemic and local antifungal therapy in intensive care unit, Med Mycol Case Rep, vol.11, pp.53-56, 2016.

F. Symoens, C. Knoop, and M. Schrooyen, Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation, J Heart Lung Transplant, vol.25, pp.603-607, 2006.

C. T. Doligalski, K. Benedict, and A. A. Cleveland, Epidemiology of invasive mold infections in lung transplant recipients, Am J Transplant, vol.14, pp.1328-1333, 2014.

E. Borghi, R. Iatta, A. Manca, M. T. Montagna, and G. Morace, Chronic airway colonization by Scedosporium apiospermum with a fatal outcome in a patient with cystic fibrosis, Med Mycol, vol.48, pp.108-113, 2010.

B. Lujik, M. B. Ekkeleenkamp, and P. A. Dejong, Effective prolonged therapy with voriconazole in a lung transplant recipient with spondylodiscitis induced by Scedosporium apiospermum, Case Rep Infect Dis, p.460313, 2011.

N. E. Rolfe, T. J. Haddad, and T. S. Wills, Management of Scedosporium apiospermum in a pre-and post-lung transplant patient with cystic fibrosis, Med Mycol Case Rep, vol.2, pp.37-39, 2013.

E. J. Denton, O. Smibert, and J. Gooi, Invasive Scedosporium sternal osteomyelitis following lung transplant: Cured, Med Mycol Case Rep, vol.12, pp.14-16, 2016.
DOI : 10.1016/j.mmcr.2016.07.001

URL : https://doi.org/10.1016/j.mmcr.2016.07.001

S. Guignard, D. Hubert, and B. Dupont, Multifocal Scedosporium apiospermum spondylitis in a cystic fibrosis patient, J Cyst Fibros, vol.7, pp.89-91, 2008.
DOI : 10.1016/j.jcf.2007.05.003

URL : https://doi.org/10.1016/j.jcf.2007.05.003

M. R. Ananda-rajah, A. Grigg, and M. A. Slavin, Breakthrough disseminated Scedosporium prolificans infection in a patient with relapsed leukemia on prolonged voriconazole followed by posaconazole prophylaxis, Mycopathologia, vol.166, pp.83-86, 2008.

R. Ohashi, M. Kato, and Y. Katsura, Breakthrough lung Scedosporium prolificans infection with multiple cavity lesions in a patient receiving voriconazole for probable invasive aspergillosis associated with monoclonal gammopathy of undetermined significance (MGUS), Med Mycol J, vol.52, pp.33-38, 2011.

A. M. Kesson, M. C. Bellemore, O. Mara, T. J. Ellis, D. H. Sorrell et al., Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (miltefosine), in combination with terbinafine and voriconazole: A case report, Clin Infect Dis, vol.48, pp.1257-1261, 2009.

W. J. Steinbach, W. A. Schell, J. L. Miller, and J. R. Perfect, Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanide, J Clin Microbiol, vol.41, pp.3981-3985, 2003.
DOI : 10.1128/jcm.41.8.3981-3985.2003

URL : https://jcm.asm.org/content/41/8/3981.full.pdf

Y. Ochi, N. Hiramoto, and H. Takegawa, Infective endocarditis caused by Scedosporium prolificans infection in a patient with acute myeloid leukemia undergoing induction chemotherapy, Int J Hematol, vol.101, pp.620-625, 2015.

K. Uno, K. Kasahara, and S. Kutsuna, Infective endocarditis and meningitis due to Scedosporium prolificans in a renal transplant recipient, J Infect Chemother, vol.20, pp.131-133, 2014.

M. Nishimori, T. Takahashi, and E. Suzuki, Fatal fungemia with Scedosporium prolificans in a patient with acute myeloid leukemia, Med Mycol J, vol.55, pp.63-70, 2014.

S. V. Bhat, D. L. Paterson, M. G. Rinaldi, and P. J. Veldkamp, Scedosporium prolificans brain abscess in a patient with chronic granulomatous disease: successful combination therapy with voriconazole and terbinafine, Scand J Infect Dis, vol.39, pp.87-90, 2007.

I. B. Gosbell, V. Toumasatos, J. Yong, R. S. Kuo, D. H. Ellis et al., Cure of orthopaedic infection with Scedosporium prolificans, using voriconazole plus terbinafine, without the need for radical surgery, Mycoses, vol.46, pp.233-236, 2003.

B. P. Howden, M. A. Slavin, A. P. Schwarer, and A. M. Mijch, Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine, Eur J Clin Microbiol Infect Dis, vol.22, pp.111-113, 2003.

J. Y. Li, T. Y. Yong, D. I. Grove, and P. T. Coates, Successful control of Scedosporium prolificans septic arthritis and probable osteomyelitis without radical surgery in a long-term renal transplant recipient, Transpl Infect Dis, vol.10, pp.63-65, 2008.

M. Studahl, T. Backteman, F. Stålhammarst?stålhammar, E. Chryssanthou, and B. Petrini, Bone and joint infection after traumatic implantation of Scedosporium prolificans treated with voriconazole and surgery, Acta Paediatr, vol.92, pp.980-982, 2003.

S. Y. Tong, A. Y. Peleg, J. Yoong, R. Handke, J. Szer et al., Breakthrough Scedosporium prolificans infection while receiving voriconazole prophylaxis in an allogeneic stem cell transplant recipient, Transpl Infect Dis, vol.9, pp.241-243, 2007.
DOI : 10.1111/j.1399-3062.2007.00203.x

M. Homa, L. Galgóczygalg´galgóczy, T. ´-oth, and E. , In vitro antifungal activity of antipsychotic drugs and their combinations with conventional antifungals against Scedosporium and Pseudallescheria isolates, Med Mycol, vol.53, pp.890-895, 2015.

M. Homa, L. Galgóczygalg´galgóczy, and T. , In vitro susceptibility of Scedosporium isolates to N-acetyl-L-cysteine alone and in combination with conventional antifungal agents, Med Mycol, vol.54, pp.776-779, 2016.

C. Biswas, T. C. Sorrell, J. T. Djordjevic, X. Zuo, K. A. Jolliffe et al., In vitro activity of miltefosine as a single agent and in combination with voriconazole or posaconazole against uncommon filamentous fungal pathogens, J Antimicrob Chemother, vol.68, pp.2842-2846, 2013.

M. Castanheira, F. P. Duncanson, D. J. Diekema, J. Guarro, R. N. Jones et al., Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods, Antimicrob Agents Chemother, vol.56, pp.352-357, 2012.

N. P. Wiederhold, D. Law, and M. Birch, Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans, J Antimicrob Chemother, 2017.
DOI : 10.1093/jac/dkx065

URL : https://academic.oup.com/jac/article-pdf/72/7/1977/17723356/dkx065.pdf

B. Cimon, J. Carrère, J. P. Chazalette, J. F. Vinatier, D. Chabasse et al., Chronic airway colonization by Penicillium emersonii in a patient with cystic fibrosis, Med Mycol, vol.37, pp.291-293, 1999.

R. C. Barton, A. M. Borman, and E. M. Johnson, Isolation of the fungus Geosmithia argillacea in sputum of people with cystic fibrosis, J Clin Microbiol, vol.48, pp.2615-2617, 2010.

S. Giraud, M. Pihet, and B. Razafimandimby, Geosmithia argillacea: an emerging pathogen in patients with cystic fibrosis, J Clin Microbiol, vol.48, pp.2381-2386, 2010.
DOI : 10.1128/jcm.00047-10

URL : https://jcm.asm.org/content/48/7/2381.full.pdf

C. Marguet, L. Favennec, and O. Matray, Clinical and microbiological efficacy of micafungin on Geosmithia argillacea infection in a cystic fibrosis patient, Med Mycol Case Rep, vol.1, pp.79-81, 2012.

S. S. De-ravin, M. Challipalli, and A. V. , Geosmithia argillacea: an emerging cause of invasive mycosis in human chronic granulomatous disease, Clin Infect Dis, vol.52, pp.136-143, 2011.

M. Machouart, D. Garcia-hermoso, and A. Rivier, Emergence of disseminated infections due to Geosmithia argillacea in patients with chronic granulomatous disease receiving long-term azole antifungal prophylaxis, J Clin Microbiol, vol.49, pp.1681-1683, 2011.

J. B. Doyon, D. A. Sutton, and P. Theodore, Rasamsonia argillacea pulmonary and aortic graft infection in an immune-competent patient, J Clin Microbiol, vol.51, pp.719-722, 2013.
DOI : 10.1128/jcm.02884-12

URL : https://jcm.asm.org/content/51/2/719.full.pdf

G. Hong, M. White, and N. Lechtzin, Fatal disseminated Rasamsonia infection in cystic fibrosis post-lung transplantation, J Cyst Fibros, vol.16, pp.3-7, 2017.
DOI : 10.1016/j.jcf.2017.01.005

J. Steinmann, S. Dittmer, J. Houbraken, J. Buer, and P. M. Rath, In vitro activity of isavuconazole against Rasamsonia species, Antimicrob Agents Chemother, vol.60, pp.6890-6891, 2016.

D. W. Denning and M. J. Bromley, Infectious disease : how to bolster the antifungal pipeline, Science, vol.347, pp.1414-1416, 2015.
DOI : 10.1126/science.aaa6097

N. Osherov and D. P. Kontoyiannis, The anti-Aspergillus drug pipeline: Is the glass half full or empty?, Med Mycol, vol.55, pp.118-124, 2017.
DOI : 10.1093/mmy/myw060

URL : https://academic.oup.com/mmy/article-pdf/55/1/118/8560093/myw060.pdf

J. R. Perfect, The antifungal pipeline: a reality check, Nat Rev Drug Discov, vol.16, pp.603-616, 2017.
DOI : 10.1038/nrd.2017.46

URL : http://europepmc.org/articles/pmc5760994?pdf=render

P. Jones, D. Binns, and H. Y. Chang, InterProScan 5: genome-scale protein function classification, Bioinformatics, vol.30, pp.1236-1276, 2014.
DOI : 10.1093/bioinformatics/btu031

URL : https://academic.oup.com/bioinformatics/article-pdf/30/9/1236/653449/btu031.pdf

C. Baxter, (. Manchester, U. ). , A. Beauvais-;-isabelle, and D. Gangneux, Rafael CantónCant´Cantón, Nina Gunde-Cimerman (Ljubljana, Slovenia), ¨ Ozge G ¨ ungörung¨ungör